Citigroup »

Rapport Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-12-31 $170k 9.6k 17.74
2024-09-30 $262k 13k 20.48

More positions owned by Citigroup

Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Spdr Gold Tr Gold Shs (GLD)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Indl (XLI)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial (XLF)

View all positions for Citigroup

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Cormorant Asset Management
Capital Research and Management Company - Division 3
Johnson & Johnson
Sofinnova Ventures
T. Rowe Price Investment Management
Goldman Sachs Group
T. Rowe Price Associates
Alliancebernstein
Trv Gp Vi
BlackRock
Vanguard Group
Citadel Advisors

View all funds holding Rapport Therapeutics